在能力圈内做事
06-12
维立志博管线里有4款ADC,LBL-054-ADC、LBL-061这些针对CDH17、EGFR靶点,虽然还在临床前,但不算晚,ADC管线也是不错的潜在增长点
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":445176109805768,"tweetId":"445176109805768","gmtCreate":1749707015403,"gmtModify":1749707016705,"author":{"id":4090740707034800,"idStr":"4090740707034800","authorId":4090740707034800,"authorIdStr":"4090740707034800","name":"在能力圈内做事","avatar":"https://static.tigerbbs.com/eae913210ead37534ccd6a5658b225e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>维立志博管线里有4款ADC,LBL-054-ADC、LBL-061这些针对CDH17、EGFR靶点,虽然还在临床前,但不算晚,ADC管线也是不错的潜在增长点</body></html>","htmlText":"<html><head></head><body>维立志博管线里有4款ADC,LBL-054-ADC、LBL-061这些针对CDH17、EGFR靶点,虽然还在临床前,但不算晚,ADC管线也是不错的潜在增长点</body></html>","text":"维立志博管线里有4款ADC,LBL-054-ADC、LBL-061这些针对CDH17、EGFR靶点,虽然还在临床前,但不算晚,ADC管线也是不错的潜在增长点","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/445176109805768","repostId":0,"isVote":1,"tweetType":1,"viewCount":429,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":116,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/445176109805768"}
精彩评论